$7.4B Deal Nets Purdue More Time, J&J Spinoff Ends Trial
Purdue Pharma received approval for more mediation time after telling a judge that it had reached definitive terms on a new $7.4 billion settlement of opioid claims; a two-week trial over...To view the full article, register now.
Already a subscriber? Click here to view full article